Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rachel Chevalier"'
Autor:
Marissa R. Keever-Keigher, Lisa Harvey, Veronica Williams, Carrie A. Vyhlidal, Atif A. Ahmed, Jeffery J. Johnston, Daniel A. Louiselle, Elin Grundberg, Tomi Pastinen, Craig A. Friesen, Rachel Chevalier, Craig Smail, Valentina Shakhnovich
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChronic inflammation of the gastrointestinal tissues underlies gastrointestinal inflammatory disorders, leading to tissue damage and a constellation of painful and debilitating symptoms. These disorders include inflammatory bowel diseases
Externí odkaz:
https://doaj.org/article/a2f85ac5e21041d7ad71c85d212e9cff
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 8, Pp 1294-1308 (2023)
Abstract Allergic conditions, such as asthma, chronic urticaria, atopic dermatitis (AD), and eosinophilic esophagitis, have long been treated with oral and topical steroids which resulted in negative off‐target effects. However, newer biologic medi
Externí odkaz:
https://doaj.org/article/0811bf5d602f459fb56c8002871d145f
Publikováno v:
Pharmaceuticals, Vol 16, Iss 6, p 889 (2023)
Gastroenterologists represent some of the earlier adopters of precision medicine through pharmacogenetic testing by embracing upfront genotyping for thiopurine S-methyltransferase nucleotide diphosphatase (TPMT) before prescribing 6-mercaptopurine or
Externí odkaz:
https://doaj.org/article/02d173e5a1c14720a0814c667467a599
Autor:
Rachel Chevalier
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 6, Pp 573-585 (2019)
RNA interference via small interfering RNA (siRNA) offers opportunities to precisely target genes that contribute to gastrointestinal (GI) pathologies, such as inflammatory bowel disease, celiac, and esophageal scarring. Delivering the siRNA to the G
Externí odkaz:
https://doaj.org/article/8f9c23df302d4d769b1a4189c3553b48
Publikováno v:
World Journal of Gastrointestinal Endoscopy. 15:407-419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57de3f496a6b6ab9b28690f6aa80a9ac
https://doi.org/10.4253/wjge.v15.i5.407
https://doi.org/10.4253/wjge.v15.i5.407
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 19:53-56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4445a8347581d1e85d2c2cb351d1e2b0
https://doi.org/10.1080/17425255.2023.2190883
https://doi.org/10.1080/17425255.2023.2190883
Publikováno v:
Digestive diseases and sciences. 62(11)
Children with active inflammatory bowel disease (IBD) are frequently underweight. Anti-tumor necrosis factor (anti-TNF) agents may induce remission and restore growth. However, its use in other autoimmune diseases has been associated with excess weig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b925212caeeb1390c557ece7f5f0fba3
https://pubmed.ncbi.nlm.nih.gov/28895012
https://pubmed.ncbi.nlm.nih.gov/28895012